Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Hur, Hoon ^a   Paik, Man Jeong ^b   Xuan, Yi ^a,c   Nguyen, Duc Toan ^d   Ham, In Hye ^a   Yun, Jisoo ^a   Cho, Yong Kwan ^a   Lee, Gwang ^a   Han, Sang Uk ^a  

^a Ajou University School of Medicine   (South Korea)

^b Sunchon National University   (South Korea)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d National Institute of Drug Quality Control   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; 3 HYDROXYBUTYRIC ACID; CARBOXYLIC ACID; FUMARIC ACID; GLUCOSE; KETONE BODY; LACTIC ACID; MALIC ACID; OXALOACETIC ACID; PYRUVIC ACID; SUCCINIC ACID; DICARBOXYLIC ACID;

ADULT; AGED; ARTICLE; CANCER PATIENT; CITRIC ACID CYCLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLIC DISORDER; MIDDLE AGED; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; STOMACH CANCER; TISSUE DIFFERENTIATION; TISSUE LEVEL; CARCINOGENESIS; GLYCOLYSIS; METABOLISM; PATHOLOGY; STOMACH TUMOR;

AGED; CARCINOGENESIS; CITRIC ACID CYCLE; DICARBOXYLIC ACIDS; FEMALE; GLUCOSE; GLYCOLYSIS; HUMANS; KETONE BODIES; MALE; STOMACH NEOPLASMS;

EID: 84902668513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098581     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66. (Pubitemid 46148091)
2. Fujii M, Kochi M, Takayama T (2010) Recent advances in chemotherapy for advanced gastric cancer in Japan. Surg Today 40: 295-300.
3. Kang H, Kauh JS (2011) Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard? Curr Treat Options Oncol 12: 96-106.
4. Lin LL, Huang HC, Juan HF (2012) Discovery of biomarkers for gastric cancer: a proteomics approach. J Proteomics 75: 3081-3097.
5. Yamashita K, Sakuramoto S, Watanabe M (2011) Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today 41: 24-38.
6. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, et al. (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379: 315-321.
7. Shin A, Kim J, Park S (2011) Gastric cancer epidemiology in Korea. J Gastric Cancer 11: 135-140.
8. Warburg O (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
9. Weber WA, Petersen V, Schmidt B, Tyndale-Hines L, Link T, et al. (2003) Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 21: 2651-2657. (Pubitemid 46606307)
10. Wieder HA, Brucher BL, Zimmermann F, Becker K, Lordick F, et al. (2004) Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22: 900-908. (Pubitemid 41103602)
11. Song H, Wang L, Liu HL, Wu XB, Wang HS, et al. (2011) Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity. Oncol Rep 26: 431-438.
12. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69: 4918-4925.
13. Griffin JL, Shockcor JP (2004) Metabolic profiles of cancer cells. Nat Rev Cancer 4: 551-561. (Pubitemid 38868624)
14. Sano T, Aiko T (2011) New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 14: 97-100.
15. Paik MJ, Cho EY, Kim H, Kim KR, Choi S, et al. (2008) Simultaneous clinical monitoring of lactic acid, pyruvic acid and ketone bodies in plasma as methoxime/tert-butyldimethylsilyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode. Biomed Chromatogr 22: 450-453. (Pubitemid 351722143)
16. Paik MJ, Lee HJ, Kim KR (2005) Simultaneous retention index analysis of urinary amino acids and carboxylic acids for graphic recognition of abnormal state. J Chromatogr B Analyt Technol Biomed Life Sci 821: 94-104.
17. Paik MJ, Ahn YH, Lee PH, Kang H, Park CB, et al. (2010) Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy. Clin Chim Acta 411: 1532-1535.
18. Noguchi Y, Marat D, Saito A, Yoshikawa T, Doi C, et al. (1999) Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology 46: 2683-2689. (Pubitemid 29454167)
19. Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, et al. (2001) Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 92: 634-641. (Pubitemid 32735200)
20. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344.
21. Bathen TF, Jensen LR, Sitter B, Fjosne HE, Halgunset J, et al. (2007) MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 104: 181-189. (Pubitemid 47086272)
22. Glunde K, Jie C, Bhujwalla ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64: 4270-4276. (Pubitemid 38802433)
23. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D (1999) Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19: 1737-1746. (Pubitemid 29392730)
24. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, et al. (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8: 352-361.
25. McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, et al. (2008) Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem 283: 22700-22708.
26. Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92: 329-333.
27. Richtsmeier WJ, Dauchy R, Sauer LA (1987) In vivo nutrient uptake by head and neck cancers. Cancer Res 47: 5230-5233. (Pubitemid 17146500)
28. Kallinowski F, Vaupel P, Runkel S, Berg G, Fortmeyer HP, et al. (1988) Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 48: 7264-7272. (Pubitemid 19014015)
29. Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, et al. (2011) Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle 10: 1271-1286.
30. Yuasa Y (2003) Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3: 592-600.
31. Tian J, Chen L, Wei B, Shao M, Ding Y, et al. (2004) The value of vesicant 18Ffluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies. Nucl Med Commun 25: 825-831. (Pubitemid 39099996)